<VariationArchive VariationID="2138497" VariationName="NM_000475.5(NR0B1):c.1292del (p.Ser431fs)" VariationType="Deletion" Accession="VCV002138497" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1878194" VariationID="2138497">
      <GeneList>
        <Gene Symbol="NR0B1" FullName="nuclear receptor subfamily 0 group B member 1" GeneID="190" HGNC_ID="HGNC:7960" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30304206" stop="30309390" display_start="30304206" display_stop="30309390" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30322538" stop="30327494" display_start="30322538" display_stop="30327494" Strand="-" />
          </Location>
          <OMIM>300473</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000475.5(NR0B1):c.1292del (p.Ser431fs)</Name>
      <CanonicalSPDI>NC_000023.11:30304699:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30304700" stop="30304700" display_start="30304700" display_stop="30304700" variantLength="1" positionVCF="30304699" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30322817" stop="30322817" display_start="30322817" display_stop="30322817" variantLength="1" positionVCF="30322816" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>S431fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.30322817del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.30322817del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.30304700del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.30304700del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009814.1" sequenceAccession="NG_009814" sequenceVersion="1" change="g.9679del">
            <Expression>NG_009814.1:g.9679del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000475.5" sequenceAccession="NM_000475" sequenceVersion="5" change="c.1292del" MANESelect="true">
            <Expression>NM_000475.5:c.1292del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000466.2" sequenceAccession="NP_000466" sequenceVersion="2" change="p.Ser431fs">
            <Expression>NP_000466.2:p.Ser431fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_858" sequenceAccession="LRG_858">
            <Expression>LRG_858:g.9679del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_858t1" sequenceAccession="LRG_858t1">
            <Expression>LRG_858t1:c.1292del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_858p1" sequenceAccession="LRG_858p1" change="p.Ser431fs">
            <Expression>LRG_858p1:p.Ser431fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000475.5(NR0B1):c.1292del (p.Ser431fs) AND multiple conditions" Accession="RCV003064681" Version="2">
        <ClassifiedConditionList TraitSetID="10091">
          <ClassifiedCondition DB="MedGen" ID="C1848296">46,XY sex reversal 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22761912</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26500747</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7609262</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10091" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
            <Trait ID="1986" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NR0B1-Related 46,XY CGD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR0B1-related 46,XY complete gonadal dysgenesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY SEX REVERSAL, DAX1-RELATED</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">46,XY sex reversal 2</ElementValue>
                <XRef ID="MONDO:0010226" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">46XY sex reversal 2, dosage-sensitive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dosage-sensitive sex reversal</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRXY2</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DSS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9159" />
                <XRef ID="9159" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="LWPES/ESPE, 2006">
                <ID Source="PubMed">18947601</ID>
              </Citation>
              <XRef ID="C1848296" DB="MedGen" />
              <XRef ID="MONDO:0010226" DB="MONDO" />
              <XRef Type="MIM" ID="300018" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6133366" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4966952|MedGen:C0342482;C1848296" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003444479" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22761912</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7609262</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26500747</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the NR0B1 protein in which other variant(s) (p.Ile439Glnfs*5) have been observed in individuals with NR0B1-related conditions (PMID: 22761912). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individuals with X-linked adrenal hypoplasia (PMID: 7609262, 26500747). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser431Ilefs*6) in the NR0B1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 40 amino acid(s) of the NR0B1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.30322817del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342482" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848296" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6133366" TraitType="Disease" MappingType="XRef" MappingValue="C1848296" MappingRef="MedGen">
        <MedGen CUI="C1848296" Name="46,XY sex reversal 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6133366" TraitType="Disease" MappingType="XRef" MappingValue="C0342482" MappingRef="MedGen">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

